7O3A
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-046
Summary for 7O3A
Entry DOI | 10.2210/pdb7o3a/pdb |
Related | 6QHL |
Descriptor | 14-3-3 protein sigma, Transcription factor p65, CHLORIDE ION, ... (8 entities in total) |
Functional Keywords | benzaldehyde, covalent fragment, p65, 1433, rela, peptide binding protein |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 2 |
Total formula weight | 28551.87 |
Authors | Wolter, M.,Ottmann, C. (deposition date: 2021-04-01, release date: 2021-06-09, Last modification date: 2024-10-23) |
Primary citation | Wolter, M.,Valenti, D.,Cossar, P.J.,Hristeva, S.,Levy, L.M.,Genski, T.,Hoffmann, T.,Brunsveld, L.,Tzalis, D.,Ottmann, C. An Exploration of Chemical Properties Required for Cooperative Stabilization of the 14-3-3 Interaction with NF-kappa B-Utilizing a Reversible Covalent Tethering Approach. J.Med.Chem., 64:8423-8436, 2021 Cited by PubMed Abstract: Protein-protein modulation has emerged as a proven approach to drug discovery. While significant progress has been gained in developing protein-protein interaction (PPI) inhibitors, the orthogonal approach of PPI stabilization lacks established methodologies for drug design. Here, we report the systematic ″bottom-up″ development of a reversible covalent PPI stabilizer. An imine bond was employed to anchor the stabilizer at the interface of the 14-3-3/p65 complex, leading to a molecular glue that elicited an 81-fold increase in complex stabilization. Utilizing protein crystallography and biophysical assays, we deconvoluted how chemical properties of a stabilizer translate to structural changes in the ternary 14-3-3/p65/molecular glue complex. Furthermore, we explore how this leads to high cooperativity and increased stability of the complex. PubMed: 34076416DOI: 10.1021/acs.jmedchem.1c00401 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.2 Å) |
Structure validation
Download full validation report